Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Apr 18, 2019 10:40am
295 Views
Post# 29644269

RE:RE:239 millions dept to SALP includes interest until 2024!

RE:RE:239 millions dept to SALP includes interest until 2024!Eric, I wondered how the SALP debt became so high. The unearned interest on the approx $120 M CAD at 10% nearly doubles the amount of the loan for which SALP is TAKING (READ STEALING) an additional 7-9 BILLION shares of PLI that was totally unearned and only imagined for the next 5 years of a loan that would end in 2019 as soon as the restructure happens and the loan is converted to equity - thus the interest is simply never earned, just stolen through greasy lawyering contrary to their fiduciary duty with representatives on the board.

I wrote the following email to disclosure@tmx.com

Sorry, but yet another piece of information in this sad story was made known to me. I had wondered how the SALP debt was shown as $229 MILLION, all I recalled was about $120 Million due in 2019 – how did that magically grow from about $120 Million to $229 MILLION?  You will note that they just recently extended the loan to 2024 which at the time was taken as a relief and that the balance sheet issue was solved until the revenue would start to flow. Now with hindsight it is obvious that this was really a further treacherous move on the part of  SALP to claim ALLTHE UNEARNED INTEREST AT THE TIME OF THE RESTRUCTURE THAT THEY CLAIM IMPROPERLY ABOUT DOUBLES THE OUTSTANDING LOAN. SO THEY ARE TAKING ANOTHER APPROX  $110 MILLION WHICH MEAN ANOTHER STOLEN 7.23 BILLION SHARES FORIMAGINARY INTEREST NEVER EARNED WHATSOEVER.
 
Respectfully,
 

Bullboard Posts